B L Sanford

Author PubWeight™ 2.91^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720.	Leukemia	2011	1.05
2	A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102.	Ann Oncol	2009	1.01
3	Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207.	Ann Oncol	2008	0.90